CN Patent
CN105985314A — 布瑞哌唑类似物的制备方法
Assigned to Shandong Topharman Pharmaceutical Co Ltd · Expires 2016-10-05 · 10y expired
What this patent protects
本发明涉及布瑞哌唑类似物的制备方法。所述制备方法操作简单易行、工艺稳定、易于控制、反应后处理方便、不对人体健康与环境产生危害、生产成本低、收率高、纯度好,适于大规模生产。
USPTO Abstract
本发明涉及布瑞哌唑类似物的制备方法。所述制备方法操作简单易行、工艺稳定、易于控制、反应后处理方便、不对人体健康与环境产生危害、生产成本低、收率高、纯度好,适于大规模生产。
Drugs covered by this patent
- Rexulti (BREXPIPRAZOLE) · Otsuka
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.